Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3

Wesley M. Stansberry, Marelize Swart, Elizabeth B. Medeiros, Todd Skaar, Victoria M. Pratt

Research output: Contribution to journalArticle

Abstract

AIMS: To validate a laboratory-developed test for the nucleoside transporter, SLC28A3, which has been associated with an increased risk of anthracycline-induced cardiomyopathy. METHODS: We used Taqman® allele discrimination to test for two variants of the SLC28A3 gene: rs7853758 (c.1381C>T) and rs885004 (c.862-360C>T). RESULTS: During the validation process, we noted that several DNA samples obtained from the Coriell Cell Repository (Camden, NJ) were positive for both the c.1381 C > T and c.862-360C>T variants and another variant allele for either c.1381 C > T or c.862-360C>T (e.g., c.1381C>T homozygous/c.862-360C>T heterozygous, c.1381C>T homozygous/c.862-360C>T homozygous). We used de-identified DNA samples from trios of family members (mother, father, and child) to establish that the c.1381 C > T and c.862-360C>T variant alleles could be inherited in cis on the same chromosome. CONCLUSIONS: Samples containing three variant alleles suggest that the c.1381 C > T and c.862-360C>T are in cis on the chromosome in some individuals and may have implications when calculating anthracycline-induced cardiomyopathy risk. In this study, we confirm a novel haplotype of SLC28A3 using familial studies.

Original languageEnglish (US)
Pages (from-to)652-655
Number of pages4
JournalGenetic Testing and Molecular Biomarkers
Volume22
Issue number11
DOIs
StatePublished - Nov 1 2018

Fingerprint

Haplotypes
Alleles
Anthracyclines
Cardiomyopathies
Chromosomes
Nucleoside Transport Proteins
DNA
Fathers
Mothers
Genes

Keywords

  • haplotype
  • pharmacogenetics
  • rs7853758
  • rs885004
  • SLC28A3

ASJC Scopus subject areas

  • Genetics(clinical)

Cite this

Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. / Stansberry, Wesley M.; Swart, Marelize; Medeiros, Elizabeth B.; Skaar, Todd; Pratt, Victoria M.

In: Genetic Testing and Molecular Biomarkers, Vol. 22, No. 11, 01.11.2018, p. 652-655.

Research output: Contribution to journalArticle

Stansberry, Wesley M. ; Swart, Marelize ; Medeiros, Elizabeth B. ; Skaar, Todd ; Pratt, Victoria M. / Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3. In: Genetic Testing and Molecular Biomarkers. 2018 ; Vol. 22, No. 11. pp. 652-655.
@article{68dbbf97132f488a86d75a035a890f34,
title = "Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3",
abstract = "AIMS: To validate a laboratory-developed test for the nucleoside transporter, SLC28A3, which has been associated with an increased risk of anthracycline-induced cardiomyopathy. METHODS: We used Taqman{\circledR} allele discrimination to test for two variants of the SLC28A3 gene: rs7853758 (c.1381C>T) and rs885004 (c.862-360C>T). RESULTS: During the validation process, we noted that several DNA samples obtained from the Coriell Cell Repository (Camden, NJ) were positive for both the c.1381 C > T and c.862-360C>T variants and another variant allele for either c.1381 C > T or c.862-360C>T (e.g., c.1381C>T homozygous/c.862-360C>T heterozygous, c.1381C>T homozygous/c.862-360C>T homozygous). We used de-identified DNA samples from trios of family members (mother, father, and child) to establish that the c.1381 C > T and c.862-360C>T variant alleles could be inherited in cis on the same chromosome. CONCLUSIONS: Samples containing three variant alleles suggest that the c.1381 C > T and c.862-360C>T are in cis on the chromosome in some individuals and may have implications when calculating anthracycline-induced cardiomyopathy risk. In this study, we confirm a novel haplotype of SLC28A3 using familial studies.",
keywords = "haplotype, pharmacogenetics, rs7853758, rs885004, SLC28A3",
author = "Stansberry, {Wesley M.} and Marelize Swart and Medeiros, {Elizabeth B.} and Todd Skaar and Pratt, {Victoria M.}",
year = "2018",
month = "11",
day = "1",
doi = "10.1089/gtmb.2018.0194",
language = "English (US)",
volume = "22",
pages = "652--655",
journal = "Genetic Testing and Molecular Biomarkers",
issn = "1945-0265",
publisher = "Mary Ann Liebert Inc.",
number = "11",

}

TY - JOUR

T1 - Report of Confirmation of the rs7853758 and rs885004 Haplotype in SLC28A3

AU - Stansberry, Wesley M.

AU - Swart, Marelize

AU - Medeiros, Elizabeth B.

AU - Skaar, Todd

AU - Pratt, Victoria M.

PY - 2018/11/1

Y1 - 2018/11/1

N2 - AIMS: To validate a laboratory-developed test for the nucleoside transporter, SLC28A3, which has been associated with an increased risk of anthracycline-induced cardiomyopathy. METHODS: We used Taqman® allele discrimination to test for two variants of the SLC28A3 gene: rs7853758 (c.1381C>T) and rs885004 (c.862-360C>T). RESULTS: During the validation process, we noted that several DNA samples obtained from the Coriell Cell Repository (Camden, NJ) were positive for both the c.1381 C > T and c.862-360C>T variants and another variant allele for either c.1381 C > T or c.862-360C>T (e.g., c.1381C>T homozygous/c.862-360C>T heterozygous, c.1381C>T homozygous/c.862-360C>T homozygous). We used de-identified DNA samples from trios of family members (mother, father, and child) to establish that the c.1381 C > T and c.862-360C>T variant alleles could be inherited in cis on the same chromosome. CONCLUSIONS: Samples containing three variant alleles suggest that the c.1381 C > T and c.862-360C>T are in cis on the chromosome in some individuals and may have implications when calculating anthracycline-induced cardiomyopathy risk. In this study, we confirm a novel haplotype of SLC28A3 using familial studies.

AB - AIMS: To validate a laboratory-developed test for the nucleoside transporter, SLC28A3, which has been associated with an increased risk of anthracycline-induced cardiomyopathy. METHODS: We used Taqman® allele discrimination to test for two variants of the SLC28A3 gene: rs7853758 (c.1381C>T) and rs885004 (c.862-360C>T). RESULTS: During the validation process, we noted that several DNA samples obtained from the Coriell Cell Repository (Camden, NJ) were positive for both the c.1381 C > T and c.862-360C>T variants and another variant allele for either c.1381 C > T or c.862-360C>T (e.g., c.1381C>T homozygous/c.862-360C>T heterozygous, c.1381C>T homozygous/c.862-360C>T homozygous). We used de-identified DNA samples from trios of family members (mother, father, and child) to establish that the c.1381 C > T and c.862-360C>T variant alleles could be inherited in cis on the same chromosome. CONCLUSIONS: Samples containing three variant alleles suggest that the c.1381 C > T and c.862-360C>T are in cis on the chromosome in some individuals and may have implications when calculating anthracycline-induced cardiomyopathy risk. In this study, we confirm a novel haplotype of SLC28A3 using familial studies.

KW - haplotype

KW - pharmacogenetics

KW - rs7853758

KW - rs885004

KW - SLC28A3

UR - http://www.scopus.com/inward/record.url?scp=85056699222&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85056699222&partnerID=8YFLogxK

U2 - 10.1089/gtmb.2018.0194

DO - 10.1089/gtmb.2018.0194

M3 - Article

C2 - 30351207

AN - SCOPUS:85056699222

VL - 22

SP - 652

EP - 655

JO - Genetic Testing and Molecular Biomarkers

JF - Genetic Testing and Molecular Biomarkers

SN - 1945-0265

IS - 11

ER -